Business Context and Reporting Period
Company: CorVel Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: December 31, 2009
Business Overview: CorVel is an independent nationwide provider of medical cost containment and managed care services, primarily for workers' compensation and auto policies. The company operates in one reportable segment: managed care, offering patient management and network solutions services to insurance companies, TPAs, and self-administered employers.
Key Financial Metrics
| Metric | Three Months Ended Dec 31, 2009 | Nine Months Ended Dec 31, 2009 |
|---|---|---|
| Revenues | $86.6 million | $250.4 million |
| Net Income | $6.7 million | $19.5 million |
| Diluted EPS | $0.54 | $1.52 |
| Gross Margin | 25.2% | 25.5% |
| Operating Cash Flow (9mo) | $26.2 million | |
| Cash and Equivalents (Dec 31, 2009) | $14.7 million (includes $1.5M customer deposits) | |
| Debt | No outstanding revolving loans; $10M credit facility available. |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 12.6% ($9.7M) for the quarter and 7.4% ($17.3M) for the nine-month period compared to the prior year. Growth was driven primarily by a 22.7% increase in patient management services (due to higher TPA utilization) and a 4.3% increase in network solutions (driven by CareIQ services).
- Profitability: Net income rose 48.2% for the quarter and 29.6% for the nine-month period. Diluted EPS increased 58.8% for the quarter, aided by both higher income and a reduction in share count.
- Expense Management: Cost of revenues increased 9.3% for the quarter, tracking with revenue growth. General and administrative (G&A) expenses increased 4.1% for the quarter but decreased 1.4% for the nine-month period due to reduced systems costs and legal expenses.
- Share Count: Weighted average diluted shares decreased 7.5% for the quarter due to aggressive share repurchases.
Guidance, Outlook, Risks, and Unusual Items
- Share Repurchases: The company repurchased 313,250 shares for $9.5 million in the quarter and 924,257 shares for $27.0 million in the nine-month period. Subsequent to the quarter end, an additional 54,706 shares were repurchased.
- Internal Controls: Management concluded that disclosure controls and procedures were not effective as of December 31, 2009, due to a material weakness in financial close and reporting (specifically regarding reconciliations, disclosure checklists, and reliance on Excel for consolidation). Remediation efforts, including implementing system-based consolidation, are underway.
- Litigation: A putative class action filed in 2005 (Kathleen Roche, D.C. v. CorVel) regarding PPO network referrals and software bias remains pending. The company cannot estimate potential losses but intends to defend vigorously.
- Outlook: Management anticipates that referral volume and bill review volume may reflect nominal growth or decrease until there is growth in work-related injuries. The company expects to continue growing software development expenditures.
Investor Verification Checklist
- Internal Control Remediation: Verify the timeline and effectiveness of the new accounting system consolidation and reconciliation controls to address the material weakness.
- TPA Service Margins: Monitor the gross margin impact of the high-cost TPA and CareIQ services driving revenue growth.
- Litigation Exposure: Track developments in the Illinois class action lawsuit regarding PPO network referrals.
- Share Repurchase Sustainability: Assess the impact of continued buybacks on liquidity, given the reduction in cash reserves from $14.7M to $7.9M (excluding customer deposits) over the nine-month period.
- Market Headwinds: Evaluate the risk of declining workers' compensation claims and the potential for customers to bring managed care services in-house.